研究单位：[1]Xuanwu Hospital, Capital Medical University,Beijing,Beijing,China,100053[2]Peking University Third Hospital[3]Peking University First Hospital[4]Beijing Hospital[5]Hospital of Chengdu University of Traditional Chinese Medicine[6]The First Affiliated Hospital of Dalian Medical University[7]Huashan Hospital[8]Shanghai Pudong Hospital[9]Shanghai Zhongshan Hospital[10]The First Affiliated Hospital of Guangzhou Medical University[11]Changhai Hospital[12]Hebei General Hospital[13]Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology[14]LanZhou University[15]The Second Hospital University of South China[16]The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School[17]The Affiliated Hospital of Qingdao University[18]Qingdao haici hospital[19]Beijing Tsinghua Changgeng Hospital[20]First Hospital of Tsinghua University[21]Shanxi Provincial People's Hospital[22]Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University[23]RenJi Hospital[24]The Luhe Teaching Hospital of the Capital Medical University[25]Beijing Friendship Hospital[26]Second Affiliated Hospital of Soochow University[27]Tianjin First Central Hospital[28]Tianjin Medical University General Hospital[29]Renmin Hospital of Wuhan University[30]First Affiliated Hospital Xi'an Jiaotong University[31]First Affiliated Hospital of Xinjiang Medical University[32]Zhejiang University[33]The First Affiliated Hospital of Zhengzhou University[34]Chinese Academy of Medical Sciences, Fuwai Hospital[35]Xiyuan Hospital of China Academy of Chinese Medical Sciences[36]Xiangya Hospital of Central South University[37]First Affiliated Hospital of Chongqing Medical University
This study is a prospective, multi-center observational study, which evaluates the effectiveness and safety of endovascular therapy in the real world for infrapopliteal arterial occlusive disease from intermittent claudication to chronic threatening limb ischemia.
